Sign Up Today and Learn More About PanTheryx Stock
Invest in or calculate the value of your shares in PanTheryx or other pre-IPO companies through EquityZen's platform.
PanTheryx Stock (PANT)
Intestinal health research, development, and commercialization products
About PanTheryx Stock
Founded
2007
Headquarters
Boulder, CO, US
Total Funding
77.3M
Industries
Science and Engineering, Health Care, Food and Beverage
PanTheryx is a U.S. medical nutrition company focused on the research, development, and commercialization of products that promote intestinal health. The company is engaged in the discovery and development of its proprietary technology platform, advancing clinical testing, and the commercialization of its products that both address the specific dietary needs of children with infectious diarrhea, and support overall intestinal health. The company’s medical nutrition products are regulated in three FDA categories: medical foods, food for special dietary use, and dietary supplements. PanTheryx was founded in 2007 by Mark A. Braman and is based in Boulder, Colorado.
PanTheryx Press Mentions
Stay in the know about the latest news on PanTheryx
Global Digestive Health Products Market to Cross ~USD 61 Billion Mark by 2030 | DelveInsight
globenewswire • Dec 03, 2024
PanTheryx® Welcomes Menopause Specialist, Jaime Seeman, M.D., OB-GYN to its Scientific Advisory Board
finance • Apr 06, 2024
These 5 Colorado companies raised the most capital in October
bizjournals • Dec 22, 2023
Digestive Health Supplements to grow by USD 7.86 billion ...
prnewswire • Dec 22, 2023
Boulder biotech firm PanTheryx raises $52M
bizwest • Nov 29, 2023
Investors in PanTheryx
Discover investors in PanTheryx stock and explore their portfolio companies
PanTheryx Management
Leadership team at PanTheryx
CEO & President
Mark A. Braman
Vice President, Corporate Development and General Counsel
Scott Hyman
Join now and verify your accreditation status to gain access to:
- PanTheryx current valuation
- PanTheryx stock price
- Available deals in PanTheryx and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading PanTheryx Stock
How to invest in PanTheryx stock?
Accredited investors can buy pre-IPO stock in companies like PanTheryx through EquityZen funds. These investments are made available by existing PanTheryx shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell PanTheryx stock?
Shareholders can sell their PanTheryx stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."